Image para href=httpspixabay.comfrusersSpectaculum-8062673utm_source=link-attribution&utm_medium=referral&utm_campaign=image&utm_content=3964970Sylv - Copie

The Basel Breast Consortium is an interdisciplinary organization committed to the development of basic, clinical and translational research projects by supporting interdisciplinary communication and mutual education in Switzerland and neighbouring cities. The presence of outstanding basic science groups, a university hospital and a medical faculty with strong clinical oncology departments, and numerous pharma companies make Basel well-positioned to be the nexus of these collaborative activities.


To discuss, design and conduct scientific projects with the potential to advance knowledge in breast cancer basic biology and therapy to the highest level of targeted therapeutic efficacy while minimizing treatment-related toxicity.


The consortium’s mission is accomplished by regular meetings and networking opportunities among basic researchers, translational research scientists, clinicians – from academia and industry – dedicated to the study of mammary gland development, as well as breast cancer research and treatment in Switzerland and neighbouring cities. Participating clinicians and researchers may have a designated interest in basic or clinical research and originate from the fields of plastic, oncologic and oncoplastic surgery, radiation and medical oncology, gynecology, pathology, radiology and genetics. Participating basic researchers may originate, among others, from a variety of disciplines, including basic cell biology, genetics, immunology, computational biology, endocrinology and fundamental molecular biology.

We organize four joint lunchtime tricycle meetings per year. The format is three 15 minutes presentations from basic/translational researchers, clinicians, and industry, while providing 15 additional minutes for discussion and networking.
We are confident that these interactions promote fruitful collaborations in the fields of breast development and breast cancer in Switzerland and neighbouring cities.


– Tuesday, June 11th, 2024 – BBC Special Lecture
» Program & Details

21-22 of October 2024 – 9th Annual BBC Meeting
» Details to be announced


Latest News:

September 23 2022: Dr. med. Walter Weber and the TAXIS study receives the International Hologic Award » More information

June 3 2021:  Ana Luísa Correia (Bentires lab) & collaborators identify the interplay of hepatic stellate cells and NK cells as a master switch of cancer dormancy in her Nature publication » More information

November 6 2020: Prof. Bentires-Alj receives the Max Cloëtta award from the Max Cloëtta foundation. » More information

January 27 2020:  Prof. Dr. med. Walter Weber receives the Annemarie Karrasch Research Award from the Propatient Foundation. » More information

June 28 2019: SAKK/Pfizer Award 2019 has been awarded to Prof. Dr. med. Walter Weber from University of Basel. » More information

June 27 2019: The team of Dr. Santamaria from the University of Fribourg (CH) published on the influence of TGFBR1 inhibition on tumor and metastasis initiating capacity of breast cancer stem cells. » See article

Any help is welcome to support our activities. If you wish to donate please do so by bank transfer on the following account:

Basler Kantonalbank, 4002 Basel
Konto Nr. 16 477.336.09
IBAN: CH76 0077 0016 0477 3360 9
Lautend auf Universitätsspital Basel, Fonds, Hebelstrasse 36, 4031 Basel
Important notice: FO141054 / YOUR NAME

Please contact for any inquiry about sponsorship and donations.

Thank you for your support !